EMVA Skin: Your Optical Window to Health, in Just 10 Seconds

Have you ever wondered if your skin tells a deeper story about your body than just its outer shade? This is not magic—it is advanced bio-photonics.

The Romanian project EMVA Skin represents a breakthrough in medical prevention: we have successfully transformed a high-precision industrial spectrophotometer into an intelligent, non-invasive screening terminal, capable of reading biochemical indices from tissues in record time, without needles or pain.

How does it work? The science behind light

In essence, EMVA Skin directs a controlled beam of light onto the skin (standard measurements are taken on the inner forearm) and analyzes how that light is reflected back, covering the spectrum between 380 nm and 730 nm.

Every key molecule in our body has a unique “spectral identity card.” They absorb light differently, and our Data Science and Machine Learning algorithm translates these mathematical micro-variations into clear health indicators.

Seamless Preventive Screening in 3 Steps
​1. Quick Health Profiling The user completes a brief, targeted questionnaire to establish essential baseline physiological and demographic context.
​2. High-Resolution Optical Scan Using a portable, industrial-grade spectrophotometer, a non-invasive scan is performed directly on the user’s forearm to capture diffuse reflectance spectra across the 380 – 730 nm range.
​3. AI-Powered Triage & Reporting Our cloud-based AI algorithm instantly analyzes the complex optical signatures of the dermal tissue. It maps general health vitality and flags subclinical anomalies or biochemical deviations, routing the user to a medical specialist for early, preventive intervention when necessary.

What can we read on the spectrogram? The 7 Key Indicators:

1. Keratin Barrier (380 – 410 nm): We analyze the density and thickness of the upper stratum corneum to detect textural changes or reactive hyperkeratosis.
2. Glycation Index / AGEs (420 – 440 nm): We monitor cellular aging and collagen stiffening caused by excess sugar, providing an early indicator for metabolic risk (prediabetes).
3. Hepatic Toxemia / Bilirubin (450 – 480 nm): We scan for specific blue light absorption to detect metabolic waste or bilirubin accumulation, assessing liver stress before visible symptoms appear.
4. Oxidative Stress / Lipofuscin (490 – 520 nm): We identify markers of cellular wear and tear generated by chronic fatigue, sleep deprivation, or free radicals.
5. Blood Footprint and Oxygenation (540 – 580 nm): We track the famous “W” profile of oxyhemoglobin. The algorithm detects if peripheral tissue is suffering from hypoxia (lack of oxygen) or poor microcirculation.
6. The “Sallow” Signature (650 – 730 nm): We evaluate the spectral slope in the red zone, a critical area that reveals the presence of low-grade systemic inflammation or burnout syndrome.
7. Hydration Matrix (700 – 730 nm): We measure the behavior of free and bound water in the deep dermis, detecting acute dehydration states even when the subject feels adequately hydrated.

A Global Technology: No Algorithmic Discrimination

One of the greatest achievements of the EMVA Skin project is its universal calibration. Most artificial intelligence algorithms in current medicine suffer from massive “ethnic bias,” having been trained only on lighter skin types (Fitzpatrick Phototypes 1-3).

The EMVA database already includes complex, labeled profiles, ranging from Phototype 2 to rare regional cases of Phototype 6 (e.g., subjects from Nigeria). By applying mathematical transfer functions, the algorithm isolates the massive screening effect of dark melanin and succeeds in reading oxygenation and glycation with the same precision on any skin type on the planet.

The Future of Prevention: Triage in 60 Seconds

EMVA Skin does not replace classic laboratory tests; instead, it acts as a digital sentinel. It is the perfect triage tool for family doctor offices, pharmacies, or nutrition centers: a rapid optical scan that tells you exactly where your body shows signs of wear, indicating which specific blood tests you need to perform at the clinic. The project is based on Diffuse Reflectance Spectroscopy (DRS), a globally studied and recognized technology.

The project is registered in the Google for Startups program and is developed with a native cloud architecture, ready to bring non-invasive prevention to a global level.

Academic Partnerships and Clinical Validation

Currently, the EMVA Skin project is undergoing the necessary steps for scientific validation within the Faculty of Medicine at “Ovidius” University in Constanța. This academic collaboration represents a central pillar in our development, primarily aimed at rigorously confirming screening results through dedicated clinical studies.

Our Vision: Accessibility and Social Responsibility

We want EMVA Skin to become a benchmark project in social responsibility. Our long-term goal is to subsidize the costs of scanning so that every citizen can benefit from at least two preventive evaluations per year, directly contributing to increased quality of life and the level of prevention in the community.

Investments and Future Development

The EMVA Skin project is entering an expansion phase, and to achieve our proposed objectives, we are looking for partners and investors to support:

• Complex software development: Implementing an advanced platform for secure management and access to the clinical database.
• Equipping medical infrastructure: Facilitating access for clinics and family doctors to spectrometry technology to integrate this tool directly into current medical practice.

Through this investment phase, we aim to scale the EMVA Skin solution, transforming it from a research project into an accessible resource for the national medical system.

“Your body never lies in the face of light. EMVA Skin just learns how to listen to it.”

If you want to learn more about our studies, view the technical documentation archived on Zenodo, or schedule a scan, please leave a comment. We are seeking partnerships with medical institutions and specialists in Constanța for clinical validation and the expansion of the EMVA Skin database. To receive technical details, you must agree that further technical discussions will take place under a Non-Disclosure Agreement (NDA).